{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T10:40:05Z","timestamp":1788518405534,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T00:00:00Z","timestamp":1713744000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12149-024-01926-4","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T06:01:51Z","timestamp":1713765711000},"page":"525-533","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Use of dose\u2013volume histograms for metabolic response prediction in hepatocellular carcinoma patients undergoing transarterial radioembolization with Y-90 resin microspheres"],"prefix":"10.1007","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1458-9392","authenticated-orcid":false,"given":"Nazim","family":"Coskun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Oguz","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aysenur Sinem","family":"Kartal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Velihan","family":"Cayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"Canyigit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,22]]},"reference":[{"issue":"10","key":"1926_CR1","first-page":"1673","volume":"41","author":"JE Dancey","year":"2000","unstructured":"Dancey JE, Shepherd FA, Paul K, Sniderman KW, Houle S, Gabrys J, et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med. 2000;41(10):1673\u201381.","journal-title":"J Nucl Med"},{"key":"1926_CR2","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00259-015-3157-8","volume":"43","author":"E Garin","year":"2016","unstructured":"Garin E, Rolland Y, Laffont S, Edeline J. Clinical impact of 99m Tc-MAA SPECT\/CT-based dosimetry in the radioembolization of liver malignancies with 90 Y-loaded microspheres. Eur J Nucl Med Mol Imaging. 2016;43:559\u201375.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1926_CR3","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","volume":"49","author":"M Weber","year":"2022","unstructured":"Weber M, Lam M, Chiesa C, Konijnenberg M, Cremonesi M, Flamen P, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2022;49(5):1682\u201399.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"4","key":"1926_CR4","doi-asserted-by":"publisher","first-page":"559","DOI":"10.2967\/jnumed.111.097469","volume":"53","author":"YH Kao","year":"2012","unstructured":"Kao YH, Tan AEH, Burgmans MC, Irani FG, Khoo LS, Lo RHG, et al. Image-guided personalized predictive dosimetry by artery-specific SPECT\/CT partition modeling for safe and effective 90Y radioembolization. J Nucl Med. 2012;53(4):559\u201366.","journal-title":"J Nucl Med"},{"key":"1926_CR5","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/BF01084369","volume":"23","author":"S Ho","year":"1996","unstructured":"Ho S, Lau W, Leung T, Chan M, Ngar Y, Johnson P, Li A. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med Mol Imaging. 1996;23:947\u201352.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1926_CR6","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/j.jvir.2023.03.011","volume":"34","author":"GM Knight","year":"2023","unstructured":"Knight GM, Gordon AC, Gates V, Talwar A, Riaz A, Salem R, Lewandowski R. Evolution of personalized dosimetry for radioembolization of hepatocellular carcinoma. J Vasc Interv Radiol. 2023;34:1214.","journal-title":"J Vasc Interv Radiol."},{"issue":"1","key":"1926_CR7","first-page":"1","volume":"7","author":"H Levillain","year":"2020","unstructured":"Levillain H, Burghelea M, Derijckere ID, Guiot T, Gulyban A, Vanderlinden B, et al. Combined quality and dose-volume histograms for assessing the predictive value of 99mTc-MAA SPECT\/CT simulation for personalizing radioembolization treatment in liver metastatic colorectal cancer. Eur J Nucl Med Mol Imaging Phys. 2020;7(1):1\u201319.","journal-title":"Eur J Nucl Med Mol Imaging Phys"},{"issue":"1","key":"1926_CR8","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","volume":"6","author":"E Garin","year":"2021","unstructured":"Garin E, Tselikas L, Guiu B, Chalaye J, Edeline J, de Baere T, et al. Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial. Lancet Gastroenterol Hepatol. 2021;6(1):17\u201329.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"11","key":"1926_CR9","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1007\/s00270-022-03215-x","volume":"45","author":"E Garin","year":"2022","unstructured":"Garin E, Guiu B, Edeline J, Rolland Y, Palard X. Trans-arterial radioembolization dosimetry in 2022. Cardiovasc Intervent Radiol. 2022;45(11):1608\u201321.","journal-title":"Cardiovasc Intervent Radiol"},{"issue":"2","key":"1926_CR10","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1148\/radiol.2016142043","volume":"280","author":"MA Lodge","year":"2016","unstructured":"Lodge MA, Wahl RL. Practical PERCIST: a simplified guide to PET response criteria in solid tumors 1.0. Radiology. 2016;280(2):576.","journal-title":"Radiology."},{"key":"1926_CR11","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s00259-011-1812-2","volume":"38","author":"F Giammarile","year":"2011","unstructured":"Giammarile F, Bodei L, Chiesa C, Flux G, Forrer F, Kraeber-Bodere F, et al. EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds. Eur J Nucl Med Mol Imaging. 2011;38:1393\u2013406.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1926_CR12","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1007\/s00259-010-1566-2","volume":"37","author":"B Lambert","year":"2010","unstructured":"Lambert B, Mertens J, Sturm EJ, Stienaers S, Defreyne L, D\u2019Asseler Y. 99m Tc-labelled macroaggregated albumin (MAA) scintigraphy for planning treatment with 90 Y microspheres. Eur J Nucl Med Mol Imaging. 2010;37:2328\u201333.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1926_CR13","first-page":"70","volume":"35","author":"W-T Leung","year":"1994","unstructured":"Leung W-T, Lau W-Y, Ho SK, Chan M, Leung NW, Lin J, et al. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. J Nucl Med. 1994;35(1):70\u20133.","journal-title":"J Nucl Med."},{"key":"1926_CR14","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1007\/s00330-020-07231-8","volume":"31","author":"A Sarwar","year":"2021","unstructured":"Sarwar A, Kudla A, Weinstein JL, Ali A, Malik R, Bullock A, et al. Yttrium-90 radioembolization using MIRD dosimetry with resin microspheres. Eur Radiol. 2021;31:1316\u201324.","journal-title":"Eur Radiol"},{"key":"1926_CR15","doi-asserted-by":"publisher","first-page":"210","DOI":"10.3389\/fonc.2014.00210","volume":"4","author":"M Cremonesi","year":"2014","unstructured":"Cremonesi M, Chiesa C, Strigari L, Ferrari M, Botta F, Guerriero F, et al. Radioembolization of hepatic lesions from a radiobiology and dosimetric perspective. Front Oncol. 2014;4:210.","journal-title":"Front Oncol"},{"key":"1926_CR16","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1007\/s00259-015-3068-8","volume":"42","author":"C Chiesa","year":"2015","unstructured":"Chiesa C, Mira M, Maccauro M, Spreafico C, Romito R, Morosi C, et al. Radioembolization of hepatocarcinoma with 90 Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology. Eur J Nucl Med Mol Imaging. 2015;42:1718\u201338.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"1926_CR17","doi-asserted-by":"publisher","first-page":"3207","DOI":"10.1038\/s41598-021-82887-w","volume":"11","author":"MH Son","year":"2021","unstructured":"Son MH, Ha LN, Bang MH, Bae S, Giang DT, Thinh NT, Paeng JC. Diagnostic and prognostic value of 99mTc-MAA SPECT\/CT for treatment planning of 90Y-resin microsphere radioembolization for hepatocellular carcinoma: comparison with planar image. Sci Rep. 2021;11(1):3207.","journal-title":"Sci Rep"},{"key":"1926_CR18","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","volume":"48","author":"H Levillain","year":"2021","unstructured":"Levillain H, Bagni O, Deroose CM, Dieudonn\u00e9 A, Gnesin S, Grosser OS, et al. International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres. Eur J Nucl Med Mol Imaging. 2021;48:1570\u201384.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"1926_CR19","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1148\/radiol.2020191606","volume":"296","author":"A-L Hermann","year":"2020","unstructured":"Hermann A-L, Dieudonn\u00e9 A, Ronot M, Sanchez M, Pereira H, Chatellier G, et al. Relationship of tumor radiation\u2013absorbed dose to survival and response in hepatocellular carcinoma treated with transarterial radioembolization with 90Y in the SARAH study. Radiology. 2020;296(3):673\u201384.","journal-title":"Radiology"},{"issue":"1","key":"1926_CR20","first-page":"9","volume":"12","author":"EB Veenstra","year":"2022","unstructured":"Veenstra EB, Ruiter SJ, de Haas RJ, Bokkers RP, de Jong KP, Noordzij W. Post-treatment three-dimensional voxel-based dosimetry after Yttrium-90 resin microsphere radioembolization in HCC. Eur J Nucl Med Mol Imaging Res. 2022;12(1):9.","journal-title":"Eur J Nucl Med Mol Imaging Res"},{"key":"1926_CR21","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00259-023-06111-9","volume":"50","author":"N Kokabi","year":"2023","unstructured":"Kokabi N, Arndt-Webster L, Chen B, Brandon D, Sethi I, Davarpanahfakhr A, et al. Voxel-based dosimetry predicting treatment response and related toxicity in HCC patients treated with resin-based Y90 radioembolization: a prospective, single-arm study. Eur J Nucl Med Mol Imaging. 2023;50:1743.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"7","key":"1926_CR22","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1097\/MNM.0000000000001395","volume":"42","author":"P d\u2019Abadie","year":"2021","unstructured":"d\u2019Abadie P, Walrand S, Hesse M, Annet L, Borbath I, Van den Eynde M, et al. Prediction of tumor response and patient outcome after radioembolization of hepatocellular carcinoma using 90Y-PET-computed tomography dosimetry. Nucl Med Commun. 2021;42(7):747\u201354.","journal-title":"Nucl Med Commun"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-024-01926-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-024-01926-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T12:03:54Z","timestamp":1719835434000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-024-01926-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,22]]},"references-count":22,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1926"],"URL":"https:\/\/doi.org\/10.1007\/s12149-024-01926-4","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,22]]},"assertion":[{"value":"5 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}